Evidence map›Paper›PMID 39976770›Full record

ArticleMolecular biology reports2025

Curcumin protects against MPP

Ramazan Çınar, Kenan Yıldızhan

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ramazan ÇınarDepartment of Biophysics, Faculty of Medicine, Bilecik Seyh Edebali University, Bilecik, Turkey.
Kenan YıldızhanDepartment of Biophysics, Faculty of Medicine, Van Yuzuncu Yil University, Van, TR-65090, Turkey. kenanyldzhan@gmail.com.ORCID http://orcid.org/0000-0002-6585-4010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is well acknowledged that neuroinflammation, mitochondrial dysfunction, and oxidative stress (OS) play a role in the etiology of Parkinson's disease (PD). Curcumin (CUR) protect neuronal cells by interfering with the production of reactive oxygen species (ROS) in neuronal cells and suppressing OS. In this study, we investigated the role of the TRPV4 channel under CUR stimulation in the PD model induced by MPP

methodsThe cells were divided into four groups: control, CUR, MPP

resultsMPP

conclusionsThe CUR treatment in the in vitro PD model created with MPP

Indexed as

1-Methyl-4-phenylpyridiniumCurcuminNeuroprotective AgentsTRPV Cation ChannelsApoptosisCalciumCell Line, TumorGlutathioneHumansLeucineMembrane Potential, MitochondrialMitochondriaNeuronsOxidative StressParkinson DiseaseReactive Oxygen Species1-Methyl-4-phenylpyridiniumCalciumCurcuminGlutathioneLeucineN-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamideNeuroprotective AgentsReactive Oxygen SpeciesSulfonamidesTRPV4 protein, humanTRPV Cation ChannelsCurcuminMPP+Parkinson’s diseaseSH-SY5Y cellsTRPV4 channel

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.